It is known that penile implants coated or impregnated with antibiotics produce lower short-term, post-surgical infection rates than implants not treated with antibiotics, but researchers from several institutions are now reporting lower infection rates over the long term, as well.
A form of testosterone replacement therapy that uses implantable testosterone pellets (Testopel) is a viable alternative to existing treatments for hypogonadism, with a number of practical advantages for patients.
The addition of a short course of hormone therapy to radiation improves outcomes for patients with intermediate-risk, early-stage prostate cancer.
Finding a solution would seem to be a core issue for those interested in reforming a health care system in which Medicare is such a core component.
However you decide to market and promote your practice, you will want to measure the impact and results of your efforts.
New urology products and services on the horizon.
Newly available urology products and services.
Use of nutritional supplements providing vitamins and higher doses of antioxidants does not appear to interfere with the efficacy of radiation therapy for prostate cancer.
Stereotactic body radiotherapy (SBRT) for prostate cancer appears to have the same impact on sexual function as other forms of radiotherapy.
Urologists share the software and technology they would most recommend to colleagues.
AUA has formed a task force to create a pool of qualified surgeons who will teach and perform male circumcision to help prevent the spread of HIV infection in sub-Saharan Africa.
The oral angiogenesis inhibitor pazopanib (Votrient) more than doubled progression-free survival versus placebo in a randomized, phase III trial of patients with advanced renal cell carcinoma.
The study adds to a growing body of literature now suggesting that ADT in combination with EBRT is not indicated for the low-risk patient.
Low-income prostate cancer patients are far more likely to undergo surgery for their disease if they are treated in a county hospital versus a private provider.
Medical practices around the country face continued challenges with managing a diverse work force that spans three generations.
Often neglected in the life insurance strategy is the estate tax consequence associated with the ownership and ultimate payout of the insurance policy's death benefit.
In children who show signs of readiness, toilet training is best initiated between the ages of 27 and 32 months.
This list of U.S.-based National Institutes of Health trials is derived from the NIH's database and includes phase II, III, and IV erectile dysfunction trials that are currently recruiting participants. This list is current as of March 17, 2010.
Recently published data analyses provide further evidence in support of assessing sexual health as a simple, low-cost strategy to augment traditional screening for cardiovascular disease (CVD) risk in men.
Results of a retrospective analysis, including data from a multi-institutional cohort of more than 1,200 men, suggest that obesity and race may be important modifiers in determining the association between diabetes and prostate cancer aggressiveness.
We asked several urologists around the country if they conducted workups on their patients with ED to determine whether there was coexisting cardiovascular disease, or if they referred patients to cardiologists for an assessment before starting ED treatment.
Erectile dysfunction is a strong predictor of death from all causes and of myocardial infarction, stroke, and heart failure in men with cardiovascular disease.
Private payer rules differ from Medicare rules. From payment for procedures to globals, bundling, coverage, and modifier usage, private payers are not required to use Medicare rules.
Research characterizing the features of putative prostate cancer stem cells and their susceptibility to telomerase inhibition has important implications for understanding the biology of prostate cancer and for suggesting a new approach to treatment of advanced disease.
The FDA has approved the first generic version of tamsulosin hydrochloride capsules, 0.4 mg, to treat BPH.
A 2-year assessment of patients implanted with the urethral bulking agent Macroplastique (Uroplasty, Minnetonka, MN) for the treatment of female stress urinary incontinence showed that 84% of patients maintained significant improvement from their 12-month assessment.
Sipuleucel-T (Provenge) extends overall survival in men with metastatic, castrate-resistant prostate cancer, investigators in Dendreon Corp.?s phase III IMPACT (IMmunotherapy for Prostate AdenoCarcinoma Treatment) study recently announced at the 2010 Genitourinary Cancers Symposium in San Francisco.
Results from a phase III trial have shown that cabazitaxel, an investigational compound, plus prednisone/prednisolone significantly improved overall survival and progression-free survival in patients with metastatic hormone-refractory prostate cancer whose disease progressed following treatment with docetaxel (Taxotere)-based chemotherapy.
Men should discuss the uncertainties, risks, and potential benefits of screening for prostate cancer before deciding whether to be tested, according to newly updated prostate cancer screening guidelines from the American Cancer Society.